Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2023 Jan 18;75(7):1462–1468. doi: 10.1002/acr.24969

Table 1.

Demographics and Clinical Features of Patients with SSc, by Presence of PH.

Variable SSc Only SSc-PH
(N = 64) (N = 66)

Demographics
Age, years (mean ± SD) 53.4 ± 10.8 57.7 ± 11.0
Male Sex, n (%) 7 (10.9%) 17 (25.8%)
Diffuse Cutaneous SSc, n (%) 29 (45.3%) 29 (43.9%)
Former or Current Smoker, n (%) 33 (51.6%) 36 (54.5%)
PH Classification
Pre-capillary PH, n (%) 0 34 (51.5%)
Post-capillary PH, n (%) 0 10 (15.2%)
Combined pre- and post-capillary PH, n (%) 0 4 (6.1%)
BNP Measurements #
BNP < 100 pg/mL 28 (82.4%) 33 (51.6%)
BNP ≥ 100 pg/mL and < 400 pg/mL 6 (17.6%) 19 (29.7%)
BNP ≥ 400 pg/mL 0 12 (18.8%)
Pulmonary Function Testing
FVC, % predicted (mean ± SD) 79.9 ± 19.2 69.8 ± 17.6
DLCO, % predicted (mean ± SD) 58.9 ± 18.4 44.3 ± 16.0
FVC/DLCO Ratio (mean ± SD) 1.5 ± 0.4 1.7 ± 0.7
Electrocardiography
Left Axis Deviation, n (%) 4 (6.3%) 12 (18.2%)
Right Axis Deviation, n (%) 0 4 (6.1%)
Right Bundle Branch Block, n (%) 4 (6.3%) 5 (7.6%)
Echocardiography
Aortic Regurgitation, n (%) 2 (3.1%) 11 (16.7%)
Mitral Regurgitation, n (%) 15 (23.4%) 20 (30.3%)
Tricuspid Regurgitation, n (%) 26 (40.6%) 37 (56.1%)
Pulmonic Regurgitation, n (%) 5 (7.8%) 15 (22.7%)
LA Dilation, n (%) 9 (14.1%) 25 (37.9%)
LVEF, % (mean ± SD) 62.2 ± 4.8 60.7 ± 9.5
LV Diastolic Dysfunction, n (%) 6 (9.4%) 21 (31.8%)
LV Hypertrophy, n (%) 8 (12.5%) 19 (28.8%)
RA Dilation, n (%) 1 (1.6%) 15 (22.7%)
RV Dilation, n (%) 2 (3.1%) 24 (36.4%)
RV Dysfunction, n (%) 0 10 (15.2%)
Pericardial Effusion, n (%) 16 (25.0%) 21 (31.8%)
Insufficient TR Jet for ePASP, n (%) 21 (32.8%) 14 (21.9%)
ePASP > 35 mmHg, n (%) 6 (9.4%) 38 (57.6%)
ePASP > 40 mmHg, n (%) 2 (3.1%) 30 (45.5%)
ePASP, mmHg (mean ± SD)* 28.6 ± 6.9 48.3 ± 16.2
Chest CT Findings
PA Diameter, mm (mean ± SD) 26.3 ± 3.6 31.1 ± 5.5

Abbreviations: BNP: B-type natriuretic peptide; CT: computed tomography; DLCO: Diffusing capacity of carbon monoxide; ePASP: Estimated pulmonary artery systolic pressure; FVC: Forced vital capacity; LA: Left atrial; LV: Left ventricular; LVEF: Left ventricular ejection fraction; PA: Pulmonary artery; PH: Pulmonary hypertension; RA: Right atrial; RV: Right ventricular; SSc: Systemic sclerosis; TR: Tricuspid regurgitant

#

For BNP, SSc Only: N = 34; SSc-PH: N = 64.

*

For ePASP, SSc Only: N = 43; SSc-PH: N = 51.